Study guide

8.2 Information Disclosure Statements (IDS) Requirements

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

8.2 Information Disclosure Statements (IDS) Requirements

Key Takeaways Explain This Topic AI

To ensure consideration by the examiner, an Information Disclosure Statement must comply with the content rules of 37 C.F.R. § 1.98 and timing provisions of 37 C.F.R. § 1.97.

Form PTO/SB/08a (or e-IDS) is used to list U.S. patents, published applications, foreign patent documents, and non-patent literature (NPL).

Timing Tiers: Tier 1 (§ 1.97(b)) requires no fee/certification; Tier 2 (§ 1.97(c)) requires a fee OR § 1.97(e) certification; Tier 3 (§ 1.97(d)) requires BOTH fee AND certification.

The § 1.97(e) certification requires that references were first cited in a foreign communication or known to Rule 56(c) individuals within the preceding 3 months.

Foreign patent documents and non-patent literature listed in an IDS generally require legible copies; for a non-English item, the applicant supplies a concise explanation of relevance, which may use a known English translation.

Last updated: August 2026

To satisfy the duty of disclosure set forth in 37 C.F.R. § 1.56, applicants submit prior art and material information to the USPTO through an Information Disclosure Statement (IDS) . Submitting an IDS is an administrative procedure governed strictly by two regulations: 37 C.F.R. § 1.98 (which dictates what must be submitted) and 37 C.F.R. § 1.97 (which dictates when and under what conditions it must be submitted). Understanding the interplay between timing tiers, fee requirements, and certification statements is one of the most frequently tested areas on the Patent Bar examination.

Content Requirements: 37 C.F.R. § 1.98

Under 37 C.F.R. § 1.98(a) , a complete and compliant Information Disclosure Statement must include four distinct items:

Itemized Listing (Form PTO/SB/08a/08b) : A list of all patents, publications, applications, or other information submitted for consideration. Standard forms PTO/SB/08a (for U.S. patents and application publications) and PTO/SB/08b (for foreign documents and non-patent literature) or their electronic equivalents (e-IDS) must be used.

Legible Copies of References : A legible copy of:

Each foreign patent document listed.

Each non-patent literature (NPL) item listed (e.g., journal articles, conference papers, website printouts).

Crucial Exception : Under 37 C.F.R. § 1.98(a)(2)(iii), copies of U.S. patents and U.S. patent application publications do not need to be submitted unless specifically requested by the examiner, as the USPTO maintains internal electronic access to U.S. patent records.

Concise Explanation of Relevance : For each cited foreign document or NPL item that is not in the English language , the applicant must provide either:

A complete English translation, OR

A concise explanation of the relevance of the document (e.g., an English-language abstract or a statement indicating which specific claims or disclosure passages relate to the claimed invention) under 37 C.F.R. § 1.98(a)(3).

Compliance with Timing and Fee Provisions : Submission of appropriate fees or certifications as mandated by 37 C.F.R. § 1.97.

If an IDS fails to comply with any requirement of § 1.98, the examiner will place the submission in the File Wrapper but will not initial or consider the non-compliant references, and the applicant will be notified of the defect.

The Three Timing Tiers: 37 C.F.R. § 1.97

The procedural obligations associated with filing an IDS depend entirely on when during examination the statement is filed. Section 1.97 divides application prosecution into three distinct timing periods or "tiers":

Timing Tier Prosecution Window Required Fee / Certification

Tier 1 (§ 1.97(b)) • Within 3 months of U.S. filing date; OR; • Within 3 months of 35 U.S.C. 371 national stage entry; OR; • Before mailing of the 1st Office Action on the merits; OR; • Before mailing of 1st Office Action after an RCE. NO Fee required AND NO § 1.97(e) Certification required.

Tier 2 (§ 1.97(c)) • After Tier 1 window closes, BUT; • Before or on the mailing date of a Final Office Action , a Notice of Allowance , or an Ex parte Quayle action. Requires EITHER :; 1. Statutory IDS Fee under 37 C.F.R. § 1.17(p); OR ; 2. Section 1.97(e) Certification Statement.

Tier 3 (§ 1.97(d)) • After mailing of Final Action, Notice of Allowance, or Ex parte Quayle action, BUT; • Before or with payment of the Issue Fee . Requires BOTH :; 1. Statutory IDS Fee under 37 C.F.R. § 1.17(p); AND ; 2. Section 1.97(e) Certification Statement.

The 37 C.F.R. § 1.97(e) Certification Statement

When filing an IDS under Tier 2 (to avoid paying a fee) or Tier 3 (where certification is mandatory alongside the fee), the applicant must include a formal certification signed by an authorized individual (inventor, practitioner of record, or assignee). Under 37 C.F.R. § 1.97(e) , the statement must certify to either of the following two provisions:

37 C.F.R. § 1.97(e)(1) : That each item of information contained in the IDS was first cited in a communication from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the IDS; OR

37 C.F.R. § 1.97(e)(2) : That no item of information contained in the IDS was cited in a communication from a foreign patent office, and to the knowledge of the person signing the certification after reasonable inquiry, no item of information contained in the IDS was known to any individual designated in § 1.56(c) more than three months prior to the filing of the IDS.

Essential Exam Rules for § 1.97(e) Certifications:

Strict 3-Month Window : The 3-month period runs from the date of the foreign office communication or the date the reference was first known to a Rule 56(c) individual to the date of filing the IDS.

No Extensions of Time : The 3-month time period in § 1.97(e) cannot be extended under 37 C.F.R. § 1.136(a) or (b).

Cannot Combine Tiers : If an applicant misses the 3-month window under § 1.97(e) in Tier 3 (after Notice of Allowance), the IDS cannot be considered by the examiner under § 1.97(d). The applicant must instead file a Petition to Withdraw the Application from Issue under 37 C.F.R. § 1.313 or file a Request for Continued Examination (RCE) under 37 C.F.R. § 1.114.

Submissions After Payment of Issue Fee

Once the Issue Fee has been paid, the USPTO will not consider any Information Disclosure Statement filed under 37 C.F.R. § 1.97. An IDS submitted after issue fee payment will simply be placed in the file wrapper unconsidered.

To have prior art considered after issue fee payment, the applicant must successfully petition to withdraw the application from issue under 37 C.F.R. § 1.313(c)(2) for the purpose of filing an RCE and submitting the IDS, or participate in special USPTO programs such as the Quick Path Information Disclosure Statement (QPIDS) program.

Loading diagram... IDS Timing Tiers Decision Flowchart